COMP <GO>
SMTI vs CDRE // EV/EBITDA & P/E VALUATION
Sanara MedTech Inc. (NASDAQ) VS. Cadre Holdings Inc. (NYSE) • 15-METRIC TALLY: SMTI 5
— CDRE 8
▲ EV/EBITDA & P/E VALUATION LEADER: CDRE
LAST: $32.92 (+0.11%) • MKT CAP: $302.4M
valuation
29.5x
LAST: $31.10 (+3.81%) • MKT CAP: $1.33B
valuation
20.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMTI VS. CDRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMTI | CDRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.70% | 42.50% | +50.20 | SMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | 11.00% | +5.30 | SMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 29.5x | 20.5x | +9.00 | CDRE | /valuation <GO> |
| Free Cash Flow Yield | 0.71% | 4.27% | -3.56 | CDRE | /fcf-yield <GO> |
| Operating Margin | 7.10% | 11.00% | -3.90 | CDRE | /operating-margins <GO> |
| Net Profit Margin | 36.40% | 7.20% | +29.20 | SMTI | /net-margins <GO> |
| Revenue Growth (YoY) | 19.00% | 7.50% | +11.50 | SMTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.16% | -1.16 | CDRE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.25 | 3.32 | -0.07 | CDRE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | CDRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.3 | 65.0 | -37.69 | CDRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.8x | 28.1x | -21.30 | SMTI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $302.4M | $1.33B | -$1.03B | CDRE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMTI REV | CDRE REV | SMTI GROSS % | CDRE GROSS % | SMTI FCF | CDRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $103.1M | $610.3M | 92.7% | 42.5% | $2.2M | $56.8M |
| FY 2024 | $86.7M | $567.6M | 90.6% | 41.1% | -$229.6K | $26.1M |
| FY 2023 | $65.0M | $482.5M | — | — | -$3.2M | $73.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMTI // BETA —
CDRE // BETA —